Kagawa R, Mori K, Yamamoto Y, Fujii T, Shimabukuro T, Morimoto T, Yamaoka Y
Second Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
World J Surg. 1995 Jul-Aug;19(4):603-7; discussion 608. doi: 10.1007/BF00294732.
Impaired glucose tolerance is a serious obstacle to major hepatic resection. To assess the predictability of surgical risk in major hepatectomy for patients with chronic liver diseases from the viewpoint of glucose metabolism, we evaluated the insulinogenic index (II) and redox tolerance index (RTI) in 48 patients who underwent major hepatectomy at our university hospital due to hepatocellular carcinoma. Patients with low II and low RTI fell into the high risk group. Based on this finding, the Z score was developed as an index of patient risk for major hepatectomy: Z = 3.11 x [II] + 1.43 x [RTI] - 2.27. When the Z score was negative, mortality reached 33.3%, but when it was positive the mortality was only 3.2%. Intraportal insulin supplementation after hepatectomy to patients with a negative Z score could reduce mortality. Preoperative evaluation of surgical risk by Z score seems to be useful for predicting patient prognosis after hepatectomy.
糖耐量受损是肝大部切除术的严重障碍。为从糖代谢角度评估慢性肝病患者肝大部切除手术风险的可预测性,我们对我校医院因肝细胞癌接受肝大部切除术的48例患者的胰岛素生成指数(II)和氧化还原耐受指数(RTI)进行了评估。II和RTI低的患者属于高风险组。基于这一发现,开发了Z评分作为肝大部切除患者风险指数:Z = 3.11×[II] + 1.43×[RTI] - 2.27。当Z评分为阴性时,死亡率达33.3%,而当Z评分为阳性时,死亡率仅为3.2%。对Z评分阴性的患者肝切除术后进行门静脉内胰岛素补充可降低死亡率。通过Z评分进行术前手术风险评估似乎有助于预测肝切除术后患者的预后。